Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Entrada Therapeutics Inc (TRDA)

Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Entrada Therapeutics Inc One Design Center Place Suite 17-500 Boston MA 02210 USA

www.entradatx.com Employees: 183 P: 857-520-9158

Sector:

Medical

Description:

Entrada Therapeutics Inc. is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles(TM) to engage intracellular targets. Entrada Therapeutics Inc. is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 397,860
Enterprise Value, $K 296,650
Shares Outstanding, K 38,219
Annual Sales, $ 210,780 K
Annual Net Income, $ 65,630 K
Last Quarter Sales, $ 1,610 K
Last Quarter Net Income, $ -44,130 K
EBIT, $ -121,560 K
EBITDA, $ -127,810 K
60-Month Beta -0.12
% of Insider Shareholders 8.11%
% of Institutional Shareholders 86.39%
Float, K 35,119
% Float 91.89%
Short Interest 949
Short Float 2.48%
Short Volume Ratio 0.42

Growth:

1-Year Return -41.32%
3-Year Return -23.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.06 on 11/06/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -2.49
EPS Growth vs. Prev Qtr -1.92%
EPS Growth vs. Prev Year -202.86%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TRDA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.42%
Return-on-Assets % -22.08%
Profit Margin % 31.14%
Debt/Equity 0.00
Price/Sales 1.92
Price/Cash Flow 6.67
Price/Book 1.18
Book Value/Share 8.96
Interest Coverage 2.73
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar